Clinical Trial Update: Immunosuppression Impact on the Metabolic Control of Kidney Transplant With Pre-Existing Type 2 Diabetes (DM) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing immunosuppression effects on metabolic control in kidney transplant recipients with pre-existing type 2 diabetes. The study sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Stanford University | Conditions: Kidney Transplant, Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED | Results posted: 2017-10-06